Asunto(s)
Humanos , Masculino , Íleon , Pólipos Intestinales/diagnóstico , Pólipos Intestinales/diagnóstico por imagen , Síndrome de Peutz-Jeghers/complicaciones , Síndrome de Peutz-Jeghers/diagnóstico , Síndrome de Peutz-Jeghers/epidemiología , Síndrome de Peutz-Jeghers/etiología , Síndrome de Peutz-Jeghers/genética , Síndrome de Peutz-Jeghers/patología , Síndrome de Peutz-Jeghers/fisiopatología , Enfermedades Intestinales/diagnóstico , Enfermedades Intestinales/etiología , Enfermedades Intestinales/terapia , AdolescenteAsunto(s)
Humanos , Masculino , Íleon , Pólipos Intestinales/diagnóstico , Pólipos Intestinales , Síndrome de Peutz-Jeghers/complicaciones , Síndrome de Peutz-Jeghers/diagnóstico , Síndrome de Peutz-Jeghers/epidemiología , Síndrome de Peutz-Jeghers/etiología , Síndrome de Peutz-Jeghers/fisiopatología , Síndrome de Peutz-Jeghers/genética , Síndrome de Peutz-Jeghers/patología , Adolescente , Enfermedades Intestinales , Tomografía Computarizada por Rayos XRESUMEN
Bromperidol therapeutic efficacy, and tolerance was studied by means of a 3-month open trial on 25 chronic psychotic female inpatients from a room at San Juan ward for medium to extensive length of stay, The Braulio A. Moyano National Psychiatric Hospital, Buenos Aires. This drug was administered orally on a single 10- to 35 mg night dose. No effect whatsoever was observed on periodic catatonia. However, its being well-tolerated and effective on chronic psychotic patients, coupled to the "bonus" of a single daily dose, turns BP into a suitable alternative drug for Haloperidol when dealing with schizophrenia, and delusions with no deficitary evolution.
Asunto(s)
Haloperidol/análogos & derivados , Trastornos Psicóticos/tratamiento farmacológico , Adolescente , Adulto , Anciano , Enfermedad Crónica , Ensayos Clínicos como Asunto , Femenino , Haloperidol/administración & dosificación , Haloperidol/efectos adversos , Haloperidol/uso terapéutico , Humanos , Pacientes Internos , Persona de Mediana Edad , Trastornos Paranoides/tratamiento farmacológico , Esquizofrenia/tratamiento farmacológicoRESUMEN
Bromperidol therapeutic efficacy, and tolerance was studied by means of a 3-month open trial on 25 chronic psychotic female inpatients from a room at San Juan ward for medium to extensive length of stay, The Braulio A. Moyano National Psychiatric Hospital, Buenos Aires. This drug was administered orally on a single 10- to 35 mg night dose. No effect whatsoever was observed on periodic catatonia. However, its being well-tolerated and effective on chronic psychotic patients, coupled to the [quot ]bonus[quot ] of a single daily dose, turns BP into a suitable alternative drug for Haloperidol when dealing with schizophrenia, and delusions with no deficitary evolution.
RESUMEN
The author makes both a historical and up-to-date review of the "schizophrenic defect" concept (S.D.). He comes to the conclusion that this is the "morbid residual" or balance left as "ideo-affective" capital after every productive psychotic outbreak. The S.D. is studied in a "Medium and Long Term" Ward with prevailing statistics amounting to 33% D.E. patients plus 9% active schizophrenic patients over a total average of 100 chronic hospitalized patients. It was found out that 33% of that universe had some scattered family whereas 19% of these patients had no family at all. The latter showed strong tendency towards isolation, slovenliness and "hospitalism". They became "passive-dependent" patients. The situational framework is analyzed. Medical staff relation ships with patients, type of treatment and the illusion created by "fictitious discharge" of E.D. under no favorable psycho-environmental conditions are taken into account. Methods to improve the situation are then outlined and discussed. The following topics are considered: correct therapeutics, family therapy, sectorization, therapeutic community, transition homes (foyers), and current legislation.
Asunto(s)
Esquizofrenia/historia , Terapia Familiar , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Historia Medieval , Hospitales Psiquiátricos , Humanos , Psicoterapia , Esquizofrenia/etiología , Esquizofrenia/terapia , Comunidad TerapéuticaRESUMEN
The author makes both a historical and up-to-date review of the [quot ]schizophrenic defect[quot ] concept (S.D.). He comes to the conclusion that this is the [quot ]morbid residual[quot ] or balance left as [quot ]ideo-affective[quot ] capital after every productive psychotic outbreak. The S.D. is studied in a [quot ]Medium and Long Term[quot ] Ward with prevailing statistics amounting to 33
D.E. patients plus 9
active schizophrenic patients over a total average of 100 chronic hospitalized patients. It was found out that 33
of that universe had some scattered family whereas 19
of these patients had no family at all. The latter showed strong tendency towards isolation, slovenliness and [quot ]hospitalism[quot ]. They became [quot ]passive-dependent[quot ] patients. The situational framework is analyzed. Medical staff relation ships with patients, type of treatment and the illusion created by [quot ]fictitious discharge[quot ] of E.D. under no favorable psycho-environmental conditions are taken into account. Methods to improve the situation are then outlined and discussed. The following topics are considered: correct therapeutics, family therapy, sectorization, therapeutic community, transition homes (foyers), and current legislation.